| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.3 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.047 | 0.3 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |